RxDoctor Payments Data

Jack Payne, PA

Physician Assistant · Goose Creek, SCNPI 1548021801

Payments from drug & device makers

$3,318in general payments, 2019–2025

Across 125 payments — averaging $26.54 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$777
  • Novo Nordisk$504
  • AbbVie$437
  • Lilly USA, LLC$194
  • Pfizer$176
  • Philips North America LLC$144
  • plus $1K from 17 others

What the payments were for

  • Food & beverage$3,318100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,318 in reported general payments places this provider in the 85th percentile of 1,852 physician assistant providers in South Carolina.

See all physician assistant providers in South Carolina

Medicare billing

Part B allowed, 2024
$34,367
Medicare patients
157
Services billed
534

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide24$25,278
FarxigaDapagliflozin Propanediol23$25,089
MounjaroTirzepatide19$22,580
Breztri AerosphereBudesonide/Glycopyr/Formoterol11$10,700
Albuterol Sulfate HfaAlbuterol Sulfate31$818
Rosuvastatin Calcium40$598
Ezetimibe18$314
Gabapentin13$292
Atorvastatin Calcium37$292
Losartan Potassium27$280
Levothyroxine Sodium19$272
Olmesartan Medoxomil22$265
Omeprazole13$226
Pravastatin Sodium12$226
Amlodipine Besylate39$225

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AstraZenecaFarxiga, Breztri Aerosphere$777$35,78934 claims
Novo NordiskOzempic$504$25,27824 claims
Lilly USA, LLCMounjaro$194$22,58019 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,852 physician assistant providers in South Carolina.

Other physician assistant in Goose Creek

See the full list for South Carolina

Where these figures come from

Is this you, or does something look wrong? →